Wedbush Morgan maintains an 'Outperform' rating on United Therapeutics (Nasdaq: UTHR), price target increased $1 to $106.

Wedbush analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE